Novartis division resubmits USFDA application for biosimilar Pegfilgrastim Farhat Nasim4 April 2019 3:45 AM GMTNew Delhi: Novartis division, Sandoz, recently announced resubmission of its Biologics License Application (BLA) for a proposed biosimilar...